优化和评估三代固体分散,以提高蒙特卢卡斯特的可溶性和溶解性
Kirti Rashmi1, Kaushiki Ash1, Abhimanyu Dev1
1Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, India.
Drug development and industrial pharmacy
|March 10, 2025
概括
像PVP和HPMC这样的第二代聚合物显著提高了使用固体分散的蒙特卢卡斯特的溶解性和溶解. 这些优化配方与纯药物和市场上销售的产品相比,表现出更好的稳定性.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 蒙特卢卡斯特是一种被广泛处方的药物,但其不良的水溶性会限制其生物可用性.
- 固体分散 (SD) 技术提供了一种有前途的方法来提高难溶性药物的可溶性和溶解率.
研究的目的:
- 通过固体分散来改善蒙特卢卡斯特 (MS) 的溶解性和溶解特性.
- 为了评估不同代的性聚合物作为Montelukast固体分散的载体的有效性.
主要方法:
- 为了确定最佳的药物载体比率,进行了相位溶解性研究.
- 用蒙特卢卡斯特与选定的聚合物 (PVP,HPMC) 制备了固体分散剂 (SD).
- 描述涉及FTIR,DSC,XRD,溶解测试和稳定性研究.
主要成果:
- 与纯药物,物理混合物和商业产品相比,蒙特卢卡斯特聚合物固体分散剂,特别是与PVP和HPMC一起,显示出明显更高的溶解率.
- FTIR,DSC和XRD分析表明SD配方的药物聚合物相互作用,降低药物的晶度 (无形状态) 和减少度.
- 优化的MS-PVP和MS-HPMC SD配方在一个月的加速储存期间表现出良好的稳定性.
结论:
- 第二代聚合物,特别是PVP和HPMC,是有效的载体,可以通过固体分散增强蒙特卢卡斯特的溶解性和溶解.
- 开发的固体分散配方提供了一种可行的策略,以提高蒙特卢卡斯特的治疗疗效.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
660
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
660
Factors Influencing Drug Absorption: Drug Dissolution
395
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
395
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
164
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
164
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
276
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
276
Factors Influencing Drug Absorption: Pharmaceutical Parameters
112
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
112
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
915
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
915


